Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.
read more
After investing more than 100 million U.S. dollars, Sartorius started up its expanded manufacturing operations in Yauco, Puerto Rico.
read more
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
read more
Concept Life Sciences has opened a new clinical and niche commercial facility to support pharmaceutical and biotechnology companies throughout the development and manufacture of API.
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain.
read more
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more
Debiopharm and Ipsen announced renewal of their Decapeptyl® agreement, which extends their partnership through 2034 for the development, manufacturing and distribution of Decapeptyl®.
read more
nanoComposix recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
read more
Hoth Therapeutics has signed contracts with providers for production of their BioLexa therapeutic, in preparation for upcoming toxicology and clinical studies.
read more
Abzena announced an accelerated program to IND.
read more
apceth Biopharma GmbH will operate as the commercial manufacturer in Europe for Zynteglo™, a product of bluebird bio.
read more
Enable Injections has entered into a multi-product development agreement with Sanofi S.A.
read more
Adial and Tedor Pharma announced they entered into a collaboration agreement to provide cGMP contract manufacturing services for AD04.
read more